CD4+ T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss

CD4+ T cells are typically considered as ‘helper’ or ‘regulatory’ populations that support and orchestrate the responses of other lymphocytes. However, they can also develop potent granzyme (Gzm)-mediated cytotoxic activity and CD4+ cytotoxic T cells (CTLs) have been amply documented both in humans and in mice, particularly in the context of human chronic infection and cancer. Despite the established description of CD4+ CTLs, as well as of the critical cytotoxic activity they exert against MHC class II-expressing targets, their developmental and memory maintenance requirements remain elusive. This is at least in part owing to the lack of a murine experimental system where CD4+ CTLs are stably induced. Here, we show that viral and bacterial vectors encoding the same epitope induce distinct CD4+ CTL responses in challenged mice, all of which are nevertheless transient in nature and lack recall properties. Consistent with prior reports, CD4+ CTL differentiation is accompanied by loss of TCF-1 expression, a transcription factor considered essential for memory T cell survival. Using genetic ablation of Tcf7, which encodes TCF-1, at the time of CD4+ T cell activation, we further show that, contrary to observations in CD8+ T cells, continued expression of TCF-1 is not required for CD4+ T cell memory survival. Whilst Tcf7-deficient CD4+ T cells persisted normally following retroviral infection, the CD4+ CTL subset still declined, precluding conclusive determination of the requirement for TCF-1 for murine CD4+ CTL survival. Using xenotransplantation of human CD4+ T cells into murine recipients, we demonstrate that human CD4+ CTLs develop and persist in the same experimental conditions where murine CD4+ CTLs fail to persist. These observations uncover a species-specific defect in murine CD4+ CTL persistence with implications for their use as a model system.

[1]  J. Sen,et al.  TCF-1 Is Required for CD4 T Cell Persistence Functions during AlloImmunity , 2023, International journal of molecular sciences.

[2]  J. Casanova,et al.  Reconciling Mouse and Human Immunology at the Altar of Genetics. , 2022, Annual review of immunology.

[3]  Mark M. Davis,et al.  Standing on the shoulders of mice. , 2022, Immunity.

[4]  N. Hellings,et al.  When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4+ T Cells , 2022, Frontiers in Immunology.

[5]  Charles H. Yoon,et al.  Landscape of helper and regulatory antitumour CD4+ T cells in melanoma , 2022, Nature.

[6]  W. Ellmeier,et al.  CD4+ Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways. , 2022, Immunology letters.

[7]  Gregory M. Chen,et al.  Decade-long leukaemia remissions with persistence of CD4+ CAR T cells , 2022, Nature.

[8]  H. Dooms,et al.  Partial STAT5 signaling is sufficient for CD4+ T cell priming but not memory formation. , 2021, Cytokine.

[9]  Xudong Zhao,et al.  TCF1 in T cell immunity: a broadened frontier , 2021, Nature Reviews Immunology.

[10]  G. Coukos,et al.  Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer , 2021, Science Advances.

[11]  Chun Jimmie Ye,et al.  Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer , 2020, Cell.

[12]  Luca Danelli,et al.  Default polyfunctional T helper 1 response to ample signal 1 alone , 2020, Cellular & Molecular Immunology.

[13]  Graham M Lord,et al.  Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells , 2020, Immunity.

[14]  Maxim N. Artyomov,et al.  MHC-II neoantigens shape tumor immunity and response to immunotherapy , 2019, Nature.

[15]  Cheryl F. Lichti,et al.  MHC-II neoantigens shape tumor immunity and response to immunotherapy , 2019, Nature.

[16]  Luca Danelli,et al.  MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells. , 2019, Blood.

[17]  M. Mehta,et al.  The Emergence and Functional Fitness of Memory CD4+ T Cells Require the Transcription Factor Thpok , 2019, Immunity.

[18]  R. D. Hatton,et al.  Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells , 2018, Science.

[19]  Luca Danelli,et al.  Correlates of Follicular Helper Bias in the CD4 T Cell Response to a Retroviral Antigen , 2018, Front. Immunol..

[20]  Jishnu Das,et al.  The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes , 2018, eLife.

[21]  N. Restifo,et al.  Epigenetic control of CD8+ T cell differentiation , 2018, Nature Reviews Immunology.

[22]  K. Rajewsky,et al.  Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses , 2018, Proceedings of the National Academy of Sciences.

[23]  J. Harty,et al.  Differential Requirements for Tcf1 Long Isoforms in CD8+ and CD4+ T Cell Responses to Acute Viral Infection , 2017, The Journal of Immunology.

[24]  Yen-Hua Chen,et al.  CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions , 2017, The Journal of experimental medicine.

[25]  S. Nutt,et al.  Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus , 2016, Cell reports.

[26]  M. Pepper,et al.  Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response , 2016, Nature Communications.

[27]  I. Dumitriu The life (and death) of CD4+CD28null T cells in inflammatory diseases , 2015, Immunology.

[28]  P. Schwartzberg,et al.  TCF1 Is Required for the T Follicular Helper Cell Response to Viral Infection. , 2015, Cell reports.

[29]  Xia Yang,et al.  The transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection , 2015, Nature Immunology.

[30]  Weiqun Peng,et al.  LEF-1 and TCF-1 orchestrate T follicular helper cell differentiation by regulating differentiation circuits upstream of Bcl6 , 2015, Nature immunology.

[31]  W. Bayer,et al.  Clonotypic Composition of the CD4+ T Cell Response to a Vectored Retroviral Antigen Is Determined by Its Speed , 2014, The Journal of Immunology.

[32]  H. Cheroutre,et al.  CD4 CTL: living up to the challenge. , 2013, Seminars in immunology.

[33]  C. Boyer,et al.  Visualization of Cytolytic T Cell Differentiation and Granule Exocytosis with T Cells from Mice Expressing Active Fluorescent Granzyme B , 2013, PloS one.

[34]  R. Ahmed,et al.  Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. , 2013, Immunity.

[35]  U. Dittmer,et al.  CD4+ T Cells Develop Antiretroviral Cytotoxic Activity in the Absence of Regulatory T Cells and CD8+ T Cells , 2013, Journal of Virology.

[36]  K. Honda,et al.  Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes , 2013, Nature Immunology.

[37]  Aneta Rogoz,et al.  Mutual expression of Runx3 and ThPOK regulates intestinal CD4+ T cell immunity , 2012, Nature Immunology.

[38]  L. Alexopoulou,et al.  Resurrection of endogenous retroviruses in antibody-deficient mice , 2012, Nature.

[39]  J. Allison,et al.  Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin , 2012, The Journal of experimental medicine.

[40]  M. Wadwa,et al.  Negative Selection by an Endogenous Retrovirus Promotes a Higher-Avidity CD4+ T Cell Response to Retroviral Infection , 2012, PLoS pathogens.

[41]  T. Strutt,et al.  Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.

[42]  A. Adler,et al.  CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation , 2011, The Journal of Immunology.

[43]  S. Kaech,et al.  Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.

[44]  H. Ohdan,et al.  Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes , 2010, Xenotransplantation.

[45]  W. Paul,et al.  Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.

[46]  R. Blasberg,et al.  Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts , 2010, The Journal of experimental medicine.

[47]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[48]  N. Killeen,et al.  Thymic OX40 Expression Discriminates Cells Undergoing Strong Responses to Selection Ligands 1 , 2009, The Journal of Immunology.

[49]  M. Tolaini,et al.  Retrovirus-Specificity of Regulatory T Cells Is Neither Present nor Required in Preventing Retrovirus-Induced Bone Marrow Immune Pathology , 2008, Immunity.

[50]  J. Stoye,et al.  B Lymphocyte Activation by Coinfection Prevents Immune Control of Friend Virus Infection1 , 2008, The Journal of Immunology.

[51]  I. Berge,et al.  Cytotoxic human CD4(+) T cells. , 2008 .

[52]  John T. Harty,et al.  Shaping and reshaping CD8+ T-cell memory , 2008, Nature Reviews Immunology.

[53]  K. Wolslegel,et al.  Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7Rα–expressing cells , 2007, The Journal of experimental medicine.

[54]  E. Remmerswaal,et al.  Emergence of a CD4+CD28− Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection , 2004, The Journal of Immunology.

[55]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[56]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[57]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[58]  F. Alt,et al.  RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. , 1999, Immunity.

[59]  J. Cooper,et al.  An Epitope Delivery System for Use with Recombinant Mycobacteria , 1998, Infection and Immunity.

[60]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[61]  K. Okuno,et al.  FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens , 1989, The Journal of experimental medicine.